HeartSciences Inc
HSCS3.190USD
+0.140+4.59%
Market hours （ET）Quotes delayed by 15 min
3.57MMarket Cap
LossP/E TTM
More Details of HeartSciences Inc Company
HeartSciences Inc. is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. The Company has libraries of artificial intelligence-enhanced electrocardiography (AI-ECG) algorithms and is developing AI-ECG solutions to be made available on either a hardware- agnostic cloud-based platform or its proprietary MyoVista wavECG device, to help identify cardiovascular disease in any care setting worldwide in a manner to suit different care providers. Its first product candidate for FDA clearance, the MyoVista wavECG, or the MyoVista, is a resting 12-lead ECG that is also designed to provide diagnostic information related to cardiac dysfunction, which has traditionally only been available through the use of cardiac imaging. The MyoVista also provides conventional ECG information in the same test. It delivers AI-ECG algorithms using existing ECG devices across a hospital or health system.
Company Info
Ticker SymbolHSCS
Company nameHeartSciences Inc
IPO dateJun 15, 2022
CEOMr. Andrew Simpson
Number of employees15
Security typeOrdinary Share
Fiscal year-endJun 15
Address550 Reserve St, Suite 360
CitySOUTHLAKE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code76092
Phone16822377781
Websitehttps://heartsciences.com/
Ticker SymbolHSCS
IPO dateJun 15, 2022
CEOMr. Andrew Simpson
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Simpson
Mr. Andrew Simpson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.38K
--
Mr. Brian Szymczak
Mr. Brian Szymczak
Independent Director
Independent Director
61.00
--
Mark T. Hilz ,
Mark T. Hilz ,
Chief Operating Officer, Secretary, Director
Chief Operating Officer, Secretary, Director
41.00
-99.08%
Mr. Bruce Bent
Mr. Bruce Bent
Independent Director
Independent Director
17.00
--
Mr. David R. Wells
Mr. David R. Wells
Independent Director
Independent Director
--
--
Ms. Danielle Watson
Ms. Danielle Watson
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew Simpson
Mr. Andrew Simpson
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
4.38K
--
Mr. Brian Szymczak
Mr. Brian Szymczak
Independent Director
Independent Director
61.00
--
Mark T. Hilz ,
Mark T. Hilz ,
Chief Operating Officer, Secretary, Director
Chief Operating Officer, Secretary, Director
41.00
-99.08%
Mr. Bruce Bent
Mr. Bruce Bent
Independent Director
Independent Director
17.00
--
Mr. David R. Wells
Mr. David R. Wells
Independent Director
Independent Director
--
--
Ms. Danielle Watson
Ms. Danielle Watson
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, May 14
Updated: Wed, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Icahn School of Medicine at Mount Sinai
2.16%
Matthews (John H)
1.77%
Astoria Strategic Wealth, Inc.
0.84%
Geode Capital Management, L.L.C.
0.42%
Simpson (Andrew)
0.20%
Other
94.61%
Shareholders
Shareholders
Proportion
Icahn School of Medicine at Mount Sinai
2.16%
Matthews (John H)
1.77%
Astoria Strategic Wealth, Inc.
0.84%
Geode Capital Management, L.L.C.
0.42%
Simpson (Andrew)
0.20%
Other
94.61%
Shareholder Types
Shareholders
Proportion
Individual Investor
2.51%
Corporation
2.51%
Investment Advisor
1.24%
Investment Advisor/Hedge Fund
0.49%
Hedge Fund
0.07%
Other
93.18%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
39
132.02K
6.46%
-26.84K
2025Q1
40
132.05K
12.22%
-6.21K
2024Q4
39
108.59K
11.08%
-22.21K
2024Q3
39
110.23K
11.34%
-17.15K
2024Q2
40
110.31K
22.15%
+69.79K
2024Q1
41
120.50K
23.97%
+81.89K
2023Q4
35
116.99K
23.49%
+83.22K
2023Q3
27
29.10K
27.79%
-2.40K
2023Q2
25
31.29K
32.13%
+2.11K
2023Q1
21
28.80K
29.57%
+2.13K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Icahn School of Medicine at Mount Sinai
48.55K
4.49%
--
--
Sep 24, 2024
Matthews (John H)
39.73K
3.68%
--
--
Sep 24, 2024
Astoria Strategic Wealth, Inc.
18.93K
1.75%
+18.93K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
9.41K
0.87%
--
--
May 31, 2025
Simpson (Andrew)
4.38K
0.41%
--
--
Sep 24, 2024
UBS Financial Services, Inc.
2.63K
0.24%
+1.32K
+101.15%
Mar 31, 2025
The Vanguard Group, Inc.
1.92K
0.18%
--
--
May 31, 2025
Tower Research Capital LLC
1.38K
0.13%
+1.28K
+1283.00%
Mar 31, 2025
Osaic Holdings, Inc.
550.00
0.05%
+550.00
--
Mar 31, 2025
Szymczak (Brian)
61.00
0.01%
--
--
Sep 24, 2024
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
May 15, 2024
Merger
100<1
May 15, 2024
Merger
100<1
May 15, 2024
Merger
100<1
May 15, 2024
Merger
100<1
Date
Type
Ratio
May 15, 2024
Merger
100<1
May 15, 2024
Merger
100<1
May 15, 2024
Merger
100<1
May 15, 2024
Merger
100<1
